Luc Debruyne, who took the top spot on Danish vaccine specialist Bavarian Nordic’s board of directors in early 2023, has stepped down from his post, effective immediately. Debruyne’s exit from the board follows—and is directly informed by—the recent implosion of a planned acquisition of Bavarian Nordic by a private equity consortium.
